Founded in 2017, CloudCath is a digital health medical device company that is dedicated to remote complication monitoring for patients undergoing catheter-based treatments. Its remote monitoring platform analyzes drainage fluid, utilizing proprietary data analysis algorithms to detect fluid property deviations, and automatically transmits notifications to healthcare providers, enabling earlier intervention in cases of catheter-associated complications like infection. CloudCath’s first product is designed for patients undergoing peritoneal dialysis.
CloudCath is a proud member of the StartX Med Summer 2018 Cohort, a showcase company in the MedTech Innovator Summer 2019 cohort & recipient of UCSF’s Rosenman Innovator award in 2018.
The company is headquartered in San Francisco and backed by leading investors in both healthcare and technology.
CloudCath is a proud member of the StartX Med Summer 2018 Cohort, a showcase company in the MedTech Innovator Summer 2019 cohort & recipient of UCSF’s Rosenman Innovator award in 2018.
The company is headquartered in San Francisco and backed by leading investors in both healthcare and technology.
Total raised: $12M
Founded date: 2017
Investors 6
| Date | Name | Website |
| - | HealthTech... | healthtech... |
| - | Head &... | headandhea... |
| - | MBX Capita... | mbxcapital... |
| - | MIT Alumni... | mitalumnia... |
| - | FundRx | fundrx.com |
| - | StartX | startx.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.02.2020 | Series A | $12M | - |
Mentions in press and media 7
| Date | Title | Description |
| 15.02.2022 | FDA clears CloudCath peritoneal dialysis at-home patient monitor | CloudCath today announced that it received FDA 510(k) clearance for its CloudCath remote monitoring system for peritoneal dialysis patients. San Francisco-based CloudCath designed the monitoring system as a data-driven, cloud-based, remote ... |
| 17.02.2020 | Catheter-Based Complication Monitoring Company CloudCath Raises $12 Million | CloudCath — a company dedicated to remote complication monitoring for patients undergoing catheter-based treatments — announced it has raised $12 million in Series A funding led by Capital Integral CloudCath — a company dedicated to remote ... |
| 14.02.2020 | CloudCath nets $12M to develop its at-home dialysis infection monitor | A startup has raised $12 million to fund its real-time system for monitoring patients undergoing dialysis at home and calling in potential complications. Sponsored by Agilent Technologies How would you like to win free bench space at Lab Ce... |
| 14.02.2020 | CloudCath nets $12M to develop its at-home dialysis infection monitor | A startup has raised $12 million to fund its real-time system for monitoring patients undergoing dialysis at home and calling in potential complications. CloudCath’s device analyzes and measures the fluids drained from the abdomens of patie... |
| 13.02.2020 | CloudCath Raises $12M in Series A Financing | CloudCath co-founders CEO Aly ElBadry (L) and CTO Eric Yu (R) (Photo: Business Wire) CloudCath, a San Francisco, CA-based provider of remote complication monitoring solutions for patients undergoing catheter-based treatments, completed a $1... |
| 13.02.2020 | CloudCath Pulls In $12M Series A | SAN FRANCISCO, CA, CloudCath today announced that it has completed a $12 million Series A financing. >> Click here for more funding data on CloudCath >> To export CloudCath funding data to PDF and Excel, click here CloudC... |
| 13.02.2020 | CloudCath closes $12M for catheter-based treatment monitoring platform |